Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Doxazosin mesilate
Clonmel Healthcare Ltd
C02CA; C02CA04
Doxazosin mesilate
1 milligram(s)
Tablet
Product subject to prescription which may be renewed (B)
Alpha-adrenoreceptor antagonists; doxazosin
Marketed
2000-01-21
Page 1 of 7 PACKAGE LEAFLET: INFORMATION FOR THE USER DOXATAN 1MG, 2MG AND 4MG TABLETS Doxazosin READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. IN THIS LEAFLET: 1. What Doxatan is and what it is used for 2. What you need to know before you take Doxatan 3. How to take Doxatan 4. Possible side effects 5. How to store Doxatan 6. Contents of the pack and other information 1. WHAT DOXATAN IS AND WHAT IT IS USED FOR The active ingredient in your tablets, doxazosin, belongs to a group of medicines known as alpha-1 antagonists. Doxatan is used to treat the following conditions. High blood pressure (essential hypertension). If left uncontrolled, high blood pressure can increase the risk of heart disease or stroke. Doxatan works by widening your blood vessels making it easier for your heart to pump blood through them. This helps to lower raised blood pressure and reduce the risk of heart disease. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE DOXATAN DO NOT TAKE DOXATAN if you are allergic to doxazosin or any of the other ingredients of this medicine (listed in section 6). Allergic reactions may be, for example, itching, reddening of the skin or difficulty breathing. if you know that you are allergic to quinazolines (e.g. prazosin, terazosin). Quinazolines are a chemical family of medicines to which doxazosin belongs to. if you have or have had a fall in blood pressure on standing up which caused dizziness, light-headedness or fainting (orthostatic hypotension). if you have benign prostatic hyperplasia (BPH) and a Read the complete document
Health Products Regulatory Authority 21 January 2022 CRN00CQMR Page 1 of 7 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Doxatan 1mg tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 1 mg doxazosin (as mesilate). Excipient with known effect Each tablet contains 40 mg lactose. For the full list ofexcipients, see section 6.1 3 PHARMACEUTICAL FORM Tablets. White, round convex tablet, embossed ‘D1’ on one side 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Doxatan 1mg are indicated for the treatment of essentialhypertension. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION POSOLOGY Unless prescribed otherwise, the following dosage regimen is recommended: Start therapy with 1mg of doxazosin once daily. Depending on the individual patient's blood pressure response, dosage may, after 1 - 2 weeks, be increased to 2mg of doxazosin once daily, if necessary, then to 4mg of doxazosin once daily, and eventually to 8mg of doxazosin once daily. Average daily dose for maintenance therapy: 2 - 4mg of doxazosin once daily. Maximum daily dose: 16mg of doxazosin. _Special populations_ Elderly people and patients with renal impairment: As the pharmacokinetic properties of doxazosin are unchanged in elderly patients and those with renal impairment, these patients can be treated with the usual dose. However, dosage should be kept as low as possible and increments made under close supervision. As doxazosin is highly protein bound, it is not removed by dialysis. Hepatic impairment: The doxazosin dose should be titrated particularly carefully in patients with impaired liver function. No clinical practice experience is available in patients with serious hepatic dysfunction (see section 4.4). Doxazosin tablets can be used as monotherapy or in combination with a thiazide diuretic, beta-blocking agents when treatment with these alone has not given the desired effect or is unsuitable. Paediatric population The safety and efficacy of doxazosin mesilate in children and adolescents have not been establi Read the complete document